Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease

While standard diets, changes in the way of life, and pathogenically oriented methods of treatment of non-alcoholic fat liver disease are often ineffective, it is necessary to develop new approaches aimed to other targets. Under the conditions of damaged intestinal barrier (“leaking bowel”), and bow...

Full description

Saved in:
Bibliographic Details
Main Authors: E. Yu. Plotnikova, Yu. V. Zakharova, T. Yu. Gracheva
Format: Article
Language:Russian
Published: Open Systems Publication 2021-06-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/562
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694842215464960
author E. Yu. Plotnikova
Yu. V. Zakharova
T. Yu. Gracheva
author_facet E. Yu. Plotnikova
Yu. V. Zakharova
T. Yu. Gracheva
author_sort E. Yu. Plotnikova
collection DOAJ
description While standard diets, changes in the way of life, and pathogenically oriented methods of treatment of non-alcoholic fat liver disease are often ineffective, it is necessary to develop new approaches aimed to other targets. Under the conditions of damaged intestinal barrier (“leaking bowel”), and bowel- liver axis, it is possible to improve natural interaction between the intestinal bacteria and peptic receptors, which contributes to the following course of events: oxidative stress, insulin-resistance, liver inflammation and fibrosis. The article also highlights possibility of intestinal microbiota modulation with probiotics.
format Article
id doaj-art-392b7eddce8e4020afcb2b5656cbc70d
institution DOAJ
issn 1560-5175
2687-1181
language Russian
publishDate 2021-06-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-392b7eddce8e4020afcb2b5656cbc70d2025-08-20T03:19:57ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812021-06-0108561Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver diseaseE. Yu. Plotnikova0Yu. V. Zakharova1T. Yu. Gracheva2ФГБОУ ВО КемГМУ МЗ РФФГБОУ ВО КемГМУ МЗ РФФГБОУ ВО КемГМУ МЗ РФWhile standard diets, changes in the way of life, and pathogenically oriented methods of treatment of non-alcoholic fat liver disease are often ineffective, it is necessary to develop new approaches aimed to other targets. Under the conditions of damaged intestinal barrier (“leaking bowel”), and bowel- liver axis, it is possible to improve natural interaction between the intestinal bacteria and peptic receptors, which contributes to the following course of events: oxidative stress, insulin-resistance, liver inflammation and fibrosis. The article also highlights possibility of intestinal microbiota modulation with probiotics.https://journal.lvrach.ru/jour/article/view/562probioticsintestinal microbiotasyndrome of excessive bacterial growthnon-alcoholic fat liver disease
spellingShingle E. Yu. Plotnikova
Yu. V. Zakharova
T. Yu. Gracheva
Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
Лечащий Врач
probiotics
intestinal microbiota
syndrome of excessive bacterial growth
non-alcoholic fat liver disease
title Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
title_full Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
title_fullStr Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
title_full_unstemmed Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
title_short Intestinal microbiom as a therapeutic target in treatment of chronic non-alcoholic fat liver disease
title_sort intestinal microbiom as a therapeutic target in treatment of chronic non alcoholic fat liver disease
topic probiotics
intestinal microbiota
syndrome of excessive bacterial growth
non-alcoholic fat liver disease
url https://journal.lvrach.ru/jour/article/view/562
work_keys_str_mv AT eyuplotnikova intestinalmicrobiomasatherapeutictargetintreatmentofchronicnonalcoholicfatliverdisease
AT yuvzakharova intestinalmicrobiomasatherapeutictargetintreatmentofchronicnonalcoholicfatliverdisease
AT tyugracheva intestinalmicrobiomasatherapeutictargetintreatmentofchronicnonalcoholicfatliverdisease